Dr. Gabrielle Lyon’s Muscle-Centric Protocol — Evidence-Based (2025-2026)

Why Muscle-Centric takes it: Crossing the ~2.5-3 g leucine threshold per meal maximally stimulates muscle protein synthesis and defends against anabolic resistance. — Forever Strong; Huberman Lab; The Lyon Protocol

What the evidence says: Protein plus resistance training reliably increases fat-free mass and strength (Morton meta, 49 RCTs). But that same meta found NO additional muscle benefit beyond ~1.6 g/kg/day, so her ~2.2 g/kg target exceeds the muscle-building ceiling (not harmful; may aid satiety/older adults). The mortality/longevity claim itself is observational.

Why Muscle-Centric takes it: Leucine is the primary molecular trigger of the mTOR/muscle-protein-synthesis switch. — Podcasts with Don Layman

What the evidence says: Leucine acutely raises muscle protein synthetic rate, but a meta-analysis in older adults found this does NOT translate into gains in lean or leg lean mass on its own (Xu). The threshold is real acute physiology, yet isolated leucine underperforms whole protein — a point Lyon herself makes.

Why Muscle-Centric takes it: Most-researched ergogenic aid; strength, lean mass, possibly cognition/mood. — Huberman Lab; Pursuit of Wellness

What the evidence says: For muscle this is A-level: meta-analyses show creatine plus resistance training adds lean tissue (~+1.4 kg) and strength in older adults. Honesty caveat: imaging-based hypertrophy gains are small, the higher-dose brain claims are only C-grade, and her avoid-coffee timing rule is not well substantiated. Strongest item in the stack.

Why Muscle-Centric takes it: Reduces inflammation and sensitizes muscle to protein; brain support. — Huberman Lab; her stack summaries

What the evidence says: The muscle-protein-synthesis signal is weak: a systematic review found only a very small effect on strength and NO effect on muscle mass or function in healthy adults (Santo Andre), and elderly meta-analyses show only minor gains, mostly in already-sarcopenic people. Her high dose exceeds typical CV-trial doses; any CV benefit is a separate story.

Why Muscle-Centric takes it: Supports muscle and bone, reduces falls in aging, corrects insufficiency. — Huberman Lab; The Lyon Protocol

What the evidence says: Grade B only for correcting documented deficiency (bone, falls in deficient elders). The specific muscle-strength claim is largely refuted in replete people: a 54-RCT meta-analysis (Bislev) found NO benefit on strength/performance and hints of harm at high doses. Reasonable to correct a low level; not a muscle-building supplement.

Why Muscle-Centric takes it: Cofactor in hundreds of reactions; sleep, muscle, metabolic health. — Huberman Lab supplement discussion

What the evidence says: Solid RCT evidence, but for blood pressure not muscle: meta-analyses show modest reductions (~2/1.8 mmHg; larger at >=400 mg/day). The sleep, cramp and longevity rationales she emphasizes are weaker. Safe and defensible, especially if intake is low, but proven for a different endpoint than her pitch.

Why Muscle-Centric takes it: Skin, connective tissue and joints; she is explicit it is NOT a muscle-building protein. — The Dr. Gabrielle Lyon Show; Huberman Lab

What the evidence says: Meta-analytic evidence supports modest skin benefits over ~90 days (de Miranda, 19 RCTs) and one RCT showed collagen + resistance training improved lean mass in sarcopenic men (Zdzieblik). Big caveats: mostly industry-funded, and collagen is an incomplete, low-leucine protein — a poor choice for muscle protein synthesis, as Lyon concedes.

Why Muscle-Centric takes it: Postbiotic mitophagy activator; gut-muscle axis and endurance. — Huberman Lab; podcast with Anurag Singh

What the evidence says: Mechanistically interesting with a handful of small, mostly manufacturer-run RCTs. The flagship 4-month trial (Singh) showed ~12% strength gains and better biomarkers but MISSED its primary endpoint (peak power), and a 2025 trial in trained runners found no performance benefit, only faster recovery. Early-stage and industry-driven.

Why Muscle-Centric takes it: Balanced EAAs (not isolated leucine) efficiently reach the anabolic threshold when whole-food protein is inadequate. — Huberman Lab; her protocol summaries

What the evidence says: A 35-RCT meta-analysis in older adults found small but significant gains in strength, mass and performance, with EAAs beating whey for handgrip (Bai). Useful for undernourished or older anabolic-resistant people and vegans, but largely redundant if total daily protein is already adequate — an optimization, not a longevity driver.

Why Muscle-Centric takes it: Nutritional insurance to cover micronutrient gaps. — Interviews; general stack discussions

What the evidence says: Large RCTs (COSMOS-Mind, COSMOS-Web) show a small but real cognition/memory benefit in older adults, and systematic review finds no increase in mortality, cancer or CVD and possible modest benefit. Not muscle-related and no demonstrated lifespan effect; a low-risk, low-yield insurance item.